Medicine Grand Rounds 2022 - Organizational Efforts to Cultivate Healthcare Professional Well-being: Before and After the Covid-19 Pandemic
2022-01-28 08:00 - 09:00 (America/New_York) | Dartmouth-Hitchcock Medical Center, One Medical Center Drive WebEx and Livestream, Lebanon, NH, 03756, United States
Presenter(s):
Tait Shanafelt, MD
This webinar is accredited for:
Dartmouth-Hitchcock designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AMA PRA Category 1 Credits™ are only available for viewing the conference webcast live, in real time. The online evaluations are time-stamped, and credit will only be awarded for online evaluations submitted on the same day the lecture takes place.
For more information on Medicine Grand Rounds, please click here.

Navigating the Intersection of Migraine and OUD Part 2: Interventional, Neuromodulation, and Behavioral Approaches
2022-02-02 16:00 - 17:00
Register Here
Presenter(s): Nathaniel M. Schuster, MD, Associate Clinic Director, Center for Pain Medicine, Associate Professor, Center for Pain Medicine, Department of Anesthesiology, UC San Diego Health, San Diego, California; Narayan R. Kissoon, MD, Consultant, Division of Headache, Department of Neurology, Consultant, Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Assistant Professor, Anesthesiology and Neurology, Mayo Clinic, Rochester, Minnesota; Heather Poupore-King, PhD, Clinical Associate Professor, Director, Pain Psychology Fellowship, Department of Anesthesiology, Perioperative and Pain Medicine, Stanford School of Medicine, Redwood City, California
Note: Once the live event has passed, please allow two weeks for the recording and slide presentations to be posted.
Target Audience
This webinar is designed for physicians, physician assistants, and nurses. The live webinar is accredited for physicians. All other non-physician attendees will receive a Certificate of Completion only.
Credit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit(s)™
Webinar Description: This webinar is the second of a 3-part series on the intersection of migraine and opioid use disorder (OUD). Chronic headache conditions such as migraine can be treated with multiple non-opioid, non-pharmacologic approaches. The faculty will explore the different types of interventional procedures, non-invasive neuromodulation, and psychological/behavioral approaches that are now available to help manage migraine, while reducing reliance on opioids and other analgesics. Appropriate referral and multimodal integration of such strategies can be especially helpful for patients with chronic headache and comorbid OUD.
Educational Objectives:

Describe the appropriate use of interventional strategies in the migraine patient
Define and explain new advances in non-invasive neuromodulation for migraine
Develop a framework to incorporate behavioral strategies into migraine management

Accreditation: The American Academy of Pain Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The American Academy of Pain Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

SAFE – Home Opioid Management Education in Older Adults: Naloxone and Opioid Awareness Program
2022-02-03 13:00 - 14:00
About the webinar: Older adults are often overlooked in public health efforts to address the U.S. opioid epidemic. Yet, in 2018, approximately one quarter of older adults 65 years old and older were prescribed an opioid to treat pain, and were nearly 3 times more likely than younger populations between 20 and 24 years old. As we age, we are more likely to experience chronic pain at a greater severity as well as opioid-related adverse effects like confusion, falls, overdose and death.

Patient education is key to reducing opioid-related harm. Many healthcare professionals and those who directly interact with older adults have a unique opportunity to educate patients on opioid risks and naloxone benefits. The goal of this webinar is to prepare home health workers to implement and improve overall patient access to harm reduction strategies, specifically naloxone. This activity will highlight the opioid epidemic and the mechanism of action and risks of opioids, particularly in older adults, and will discuss common misconceptions related to naloxone including side effects when administered to someone not overdosing from opioids, legal ramifications of administering naloxone to a stranger, and insurance coverage when accessing naloxone at the pharmacy.

Presenters:

Jennie Jarrett, PharmD, BCPS, MMedEd, FCCP
Abigail Elmes, PharmD, BCPS

Sponsor: American Academy of Addiction Psychiatry (AAAP)

Cost: No Fee

Target audience: This webinar is designed for nurses, physicians, social workers, and home health workers or care coordinators. The live webinar is accredited for physicians, nurses, PAs, social workers, pharmacists and other health professionals or learners.

Credit designations available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit

Educational objectives: At the conclusion of this activity participants should be able to:

Discuss the risks associated with opioid use, particularly in older adults
Describe how to recognize an opioid-related overdose
Explain how to access and use naloxone for the reversal of opioid overdoses

Register Now

Developing Clinical Study Budgets for Sponsors
2022-02-07 12:30 - 14:30
Register for this interactive webinar! The deadline to register is January 31st.
Unable to attend live? Register for the On-Demand course, available the week following.
This training is available to research teams affiliated with the NIDA Clinical Trials Network on a first-come-first-serve basis. Depending on the level of responses, there may be limited availability.
Description:
In an environment where studies are becoming more challenging to execute and taking more resources and time than anticipated, it is key to develop a solid and flexible budget to allow for study execution challenges. In developing a budget it is critical to address all standard line items such as reimbursement for procedures, but how can the oversight and follow-up time be accurately calculated? How does Fair Market Value (FMV) criteria factor into budget development? What questions should be asked to determine additional, unwritten, study expectations? What are some key elements leading to delayed budget negotiation and approval? This web seminar will address the fundamentals of budget development and considerations for ensuring that budgets are developed fairly to ensure that sites are appropriately reimbursed for study expectations.
This interactive webinar is intended for:
Project Managers, Clinical Research Associates, Clinical Research Associate Managers, Contract and Budget Management Personnel, Directors in Clinical Operations, Site Managers, Principal Investigators, Study Coordinators, Site Budget and Contract Representatives

The 411 on Cannabis Edibles
2022-02-16 12:00 - 13:00
This presentation will focus on education about the behavioral pharmacology of oral cannabis, aka edibles. Following this lecture, attendees should be able to differentiate the expected effects of oral versus inhaled cannabis and be able to advise patients with respect to clinical decision making related to oral cannabis use. Register at this link: The 411 on Cannabis Edibles

Ryan Vandrey’s research focuses primarily on the behavioral pharmacology of cannabis (marijuana) and includes controlled laboratory studies with adult research volunteers, clinical trials, web-based survey research, and natural history studies with patient populations using cannabis/cannabinoids for therapeutic purposes. He has been involved with a broad range of studies related to the risks and benefits of medicinal cannabis use, the effects of cannabis use on sleep, cannabis withdrawal and the treatment of Cannabis Use Disorder, cannabis product testing, and developing measures of cannabis use behavior. In addition, he has also been engaged in research on nicotine and tobacco regulatory science and treatment. Dr. Vandrey aspires to conduct objective research that addresses critical questions related to regulation and policy. He received his BA from the University of Delaware and his PhD from the University of Vermont in 2005.

Register Now

Peer-Led Innovations in Reentry Support Programming: Towards Holistic Recovery
2022-02-16 15:00 - 16:00
REGISTER HERE
Presenter(s):
Sandra D. Smith, PhD, PRSS, RPS, Peer Programs Manager @Via Hope, Mental Health Resource of Texas; David Johnson, Policy and Research Liaison @Grassroots Leadership, Texas; Daryl McGraw, MA, CAC, CCJP, Founder @Formerly, Inc., Connecticut
Description:
Reentry Peer Specialists are equipped with unique knowledge and expertise from lived experience to provide critical supports to individuals reentering the community after incarceration. Recent peer-led developments in the field provide more opportunities to support reentry peer specialists and address the critical needs that people face upon reentry. This webinar will provide information about supporting reentry peer specialists and reentry peer support programs through providing certification, training, and the knowledge and resources to effectively support people in transition from incarceration to the community. Three presenters will discuss the opportunities that come with training and education, along with the policy and practice challenges of supporting people in recovery who are transitioning back to the community, including peer support specialists, themselves.
Learning Objectives:
Upon the conclusion of this webinar, attendees should be able to list three strategies for supporting reentry peer specialists, connect policy and practice considerations for reentry peer support across the eight dimensions of wellness, and describe two key competencies for reentry peer support.

Portraits of Diversity, Equity, and Inclusion Efforts in Behavioral Health Nationwide
2022-02-17 15:00 - 16:00
REGISTER HERE
Description:
Efforts nationwide to promote diversity, equity, and inclusion (DEI) are critical to advancing a more just and equitable society. However, the strategies and approaches to promoting equity can be drastically different given the organizations leading these efforts as well as the regional and cultural contexts in which they occur. Please join NACBHDD and Optum as we explore DEI efforts nationwide from state, local, and corporate partners.

Psychiatry Grand Rounds 2022 - Marijuana as Medicine? Weeding Out the Issues
2022-02-22 08:00 - 09:00 | Dartmouth-Hitchcock Medical Center, One Medical Center Drive Aud G, Lebanon, NH, 03756, United States
Presenter(s):
Deepak Cyril D’Souza, MD
This webinar is accredited for:
The webinar provides a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For more information on Psychiatry Grand Rounds, please click here.

Exploring the Link Between Substance Use Prevention and Structural Racism
2022-02-23 13:00 - 14:30
For more information and to register for this webinar, please click HERE.
Presenter(s):
Anam Siddiqi, MPHc is currently pursuing her MPH in Health Policy Analysis and Evaluation from the University of Maryland. Ms. Siddiqi’s interests include reducing health disparities, improving health care systems, and promoting community collaboration.
Description:
Understanding the role structural racism plays in society and its relationship to substance use disorders is critical to prevention and promoting healthy behaviors. This webinar will focus on identifying common systems, policies, and programs that negatively impact people of color, understanding how stress from dealing with racism can lead to substance use, and what steps public health professionals can take to mitigate their role in propagating racist systems.
Learning Objectives:

Define, structural racism, understand its history, and recognize how it can manifest in the behavioral health setting
Mitigate organizational and individual role in propagating structural racism
Understand the link between racism, stress and trauma and identify how experiencing racism can lead to substance use
Understand how to develop tactics to prevent substance use and promote healthy coping mechanisms

In order to be eligible for the 1.25 contact hours/certificate of attendance, you must join the live webinar in Zoom. Certificates must be requested within one week of the event and will be processed within 30 days.
If you are having issues accessing the room/application at the time of the event: Please email webinars@danyainstitute.org at the start of the webinar so that we can assist you.

Gender Diversity in Our Community
2022-02-23 19:30 - 21:00
REGISTER HERE!
Presenter(s):
Dr. Jack Turco, Director, Transgender Health Program, DHMC; Dr. Kay Jankowski, Child & Adolescent Psychologist, Director of Psychology Services, DHMC; Parents of transgender/non-binary children; Transgender/non-binary young adults
Description:
Everyone has a gender identity and a core need for it to be known. In this inspiring panel discussion, our neighbors who are transgender or gender-nonbinary share from the heart about their lived experiences. Local parents of gender-nonconforming kids and medical gender experts explain what gender is and explore hurdles and hopes for better understanding. Let’s learn by listening!
To protect our neighbors and loved ones, no audio or video recording of this event shall be permitted.
Please reach out to OpenHeartEd@gmail.com with any questions about the event.

Alcohol is STILL a Drug: An Exploratory Webinar Series
2022-03-01 11:00 - 11:30
REGISTER HERE
Description:
The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
Alcohol is STILL a drug. The opioid crisis, increase in stimulant misuse, and marijuana legalization dominate the news— yet alcohol remains the number one substance causing health, social, legal and financial problems throughout the US. While this series will focus on the hopefulness of recovery from alcohol use disorder, we’ll also take a deep dive into what we know about the full impact of alcohol overuse and the ways it affects every person in the US.
Learning Objectives:

Summarize the current impacts of problematic alcohol use in various/special populations, including pregnant women, youth, rural, and minority populations.
Assess and prioritize alcohol reduction efforts in targeted settings.
Describe the current efforts to curb problematic alcohol use, including best practices in providing treatment.

Certificates:
Certificates of attendance will be emailed to all participants who attend the sessions in full.

Evidence-Based Strategies for Preventing Opioid Overdose
2022-03-07 13:00 - 14:30
Join us on March 7th from 1-2:30 p.m. (ET) for a webinar and Q&A to discuss key strategies to preventing opioid overdose with experts from the Centers for Disease Control and Prevention (CDC).
Provisional data from the CDC’s National Center for Health Statistics shows that there were over 100,300 drug overdose deaths in the United States from April 2020 – April 2021, a nearly 30% increase from the year prior. Given this increase in overdose deaths across the U.S., it is more important than ever to understand the evidence-based strategies that are available to address opioid use disorderin our communities.
Dr. Jennifer J. Carroll, a dual trained medical anthropologist and public health researcher, and Michelle Putnam from the CDC’s Division of Overdose Prevention will discuss designing and implementing effective opioid overdose prevention strategies, including targeted naloxone distribution, the importance of medication for addiction treatment (MAT), syringe service programs, and more.

Register now!

Opioid Use Disorder in Women
2022-03-08 12:00 - 13:00
Presenter: Kathleen Brady, MD, PhD, Distinguished Professor, Medical University of South Carolina
Sponsor: American Psychiatric Association (APA)
Cost: No Fee
Target audience: Interprofessional teams, psychiatrists, physicians, nurses, physician assistants. The live webinar is accredited for physicians.
Credit Designations Available: a maximum of 1.0 AMA PRA Category 1 Credit™
About the webinar: Exacerbated by the COVID-19 pandemic, the opioid epidemic in the United States is a dangerous reality that affects all demographics. In this presentation, gender differences in opioid use disorders will be discussed from an epidemiologic perspective. Understanding the differences in trends by gender can help clinicians treat the patient, rather than treating the condition. Neurobiological and social determinants will also be reviewed as the differences vary greatly by gender. Finally, treatment implications will be discussed so we can better understand the impact of tailored OUD treatment.
Educational objectives: At the conclusion of this activity participants should be able to:

Apply the epidemiologic differences in the prevalence of OUD to your practice setting.
Identify the gender differences in neurobiology of OUD when treating patients.
Evaluate the patient treatment outcomes based on gender.

Register Now

Acute Pain Management in the Individual with Opioid Use Disorder
2022-03-08 14:00 - 15:00
https://attendee.gotowebinar.com/register/614757163383157773
Presenter: Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN, FAANP
Nurse Practitioner, Section of Palliative Medicine, Associate Professor, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
Sponsoring organization: American Society for Pain Management Nursing (ASPMN)
Target audience: Nurses, nurse practitioners, physicians, physical therapists, or psychologists
About the webinar: The purpose of this activity is to provide an overview of pharmacologic and nonpharmacologic strategies to manage ‎acute pain in the individual who has a substance use disorder‎. Strategies to manage acute pain in the 1) individual who is actively misusing substances 2) the individual who is ‎taking medications for opioid use disorder and 3) the individual in long-term recovery in an abstinence based ‎program will be outlined using a case based approach.
Educational objectives:

Develop treatment strategies to treat acute pain for individuals with substance/opioid use disorder (SUD/OUD)‎
Discuss acute pain management strategies for those on medications for opioid use disorder
Describe safe discharge strategies for the patient with acute pain and co-morbid SUD/OUD

Register Now

Understanding the Conflict Between Withdrawal and Disease Avoidance in the Risk Networks of People Who Inject Drugs in Rural Puerto Rico: A Network Statistical Approach
2022-03-09 12:00 - 13:00
UVM Vice President of Research Kirk Dombrowski, PhD will present “Understanding the Conflict Between Withdrawal and Disease Avoidance in the Risk Networks of People Who Inject Drugs in Rural Puerto Rico: A Network Statistical Approach.”

This talk will provide audience members with information on research conducted on the topic of opioid addiction. The work described was funded by a grant from the National Institutes of Health/National Institute of Drug Abuse, and present recent analyses and previously published results. By the end of the lecture, attendees should be able to better describe the conjoined forces of addiction and disease risk among injecting drug users in rural Puerto Rico.

Kirk Dombrowski, PhD became vice president for research at the University of Vermont (UVM) in April 2020. Prior to joining UVM, Dr. Dombrowski held several leadership positions at the University of Nebraska (UNL). He was the founding director of the UNL’s Rural Drug Addiction Research Center, an NIH designated Center of Biomedical Research Excellence; interim director of the Nebraska Center for Virology, a ~90,000-square-foot biochemistry research institute; and director of UNL’s Minority Health Disparities Initiative, a university-wide faculty, recruitment, development, and community engagement initiative that he was brought to Nebraska to lead in 2013. A cultural anthropologist by training, Dr. Dombrowski is also an active researcher whose work straddles the social and behavioral health sciences, a link he has used to address issues public of concern and social good, such as HIV infection dynamics, drug and alcohol addiction, minority health disparities, and suicide prevention in Native American/First Nation communities. His research has received funding from NSF, NIH, and numerous foundation sources, and his published work has appeared in social science, computer science and health science journals.

Register Now

Cannabis in the Era of Commercialization
2022-03-09 12:00 - 13:30
REGISTER HERE
Description:
Cannabis policy had undergone rapid change in New England over the past decade. All New England states have some form of medical cannabis policy, while now four of the six states have legalized cannabis for adult use. This presentation will take a look at what is happening with cannabis policy in New England, examine the potential implications for risk factors associated with cannabis use disorder, and what the emerging science is telling us in terms of how to reduce harms for those who may be using cannabis.
Presenter(s):
Scott Gagnon (MPP, PS-C) is a Certified Prevention Specialist, Associate Executive Director of AdCare Educational Institute of Maine, Inc., and Director of SAMHSA’s New England Prevention Technology Transfer Center (PTTC). Scott is a national speaker on a variety of prevention topics, including cannabis policy and prevention, opioid prevention, and prevention workforce development. Scott currently serves as a Co-Chair of the national Technology Transfer Center SBIRT Coordination workgroup, and previously served as Chair of the national PTTC Network Cannabis Prevention Work Group. Scott serves as a board member of the Maine Recovery Coach Certification Board and is a member representing public health on Maine’s Marijuana Advisory Commission. Scott has previously served as Co-Chair of the Prevention Task Force for the Maine Opiate Collaborative, and has also previously served on the SAMHSA, Center for Substance Abuse Prevention National Advisory Council.
Moderator(s):
Christine McKenna (MS, LICSW, MLADC, CCTP) NEARCP Board of Directors member since 2015; Director, Rockingham County Drug Treatment Court – NH
Certificates/Credits:
This webinar has been approved by the New England Addiction Technology Transfer Center, as a National Association of Alcohol and Drug Abuse Counselors (NAADAC) Approved Education Provider, for 1.5 educational credit (CE), NAADAC Provider #62652.

Racial Inequities in NIH Grant Funding
2022-03-10 14:30 - 15:30
Join us at the Rural Drug Addiction Research (RDAR) Center’s Seminar Series!
Join us for our March Seminar Series event featuring a presentation by Michael Taffe, PhD on “Racial Inequities in NIH Grant Funding.” This presentation will overview a persisting disparity in NIH grant award funding, that leaves proposals submitted by Black Principal Investigators at a substantial disadvantage. The talk will address how this has been shown to lead to a disparity in which topics of research are funding and how this may contribute to the underfunding of research on critical health questions that are of interest to non-majority populations.
This event is FREE and OPEN to the public. All are welcome, and there is no charge to attend this event. We will be live streaming and recording the talk. You can register, and receive your unique connection information, for this event by clicking the button above or by using the following link: go.unl.edu/f8ea.

When It’s Time To Come Down, Weaning Opioids With Compassion
2022-03-15 13:00 - 14:00
Presenter: Megan Filoramo, MSN, APN-C, Pain Management NP, Educator and Nurse Coach, NJ Pain Consultants/Altair Health
Sponsoring organization: American Society for Pain Management Nursing (ASPMN)
Target audience: Nurses, nurse practitioners, physicians, physical therapists, or psychologists
About the webinar: Compassionate weaning of opioids should include both pharmacological and emotional support. There are options for both slow tapers and abrupt cessation, and selection should be based on individualized patient needs and on a shared decision-making model. This process should include not only a clear outline of the treatment plan but also alternative treatments for the pain, appropriate pharmacologic treatment of withdrawal symptoms, frequent patient re-evaluation and revision of the plan as needed. To adequately support the patient through this process, it is critical patients understand the weaning does not equate abandonment by their clinical team. Opioid tapering does not need to contribute to patient suffering.
Educational objectives:

Identify 3 pharmacologic approaches to weaning opioids.
Describe what a shared decision making model looks like in the setting of opioid weaning
List 3 components of emotional support necessary for patient success with weaning

Register Now

National Drug and Alcohol Facts Week
2022-03-21 - 2022-03-27
For more information about this event, please visit their website.
Description:
Join NIDA for NDAFW and help share facts about drugs, alcohol, and addiction in your community. Sign up for emails from NDAFW for the latest news, planning tips, and free resources to support your NDAFW activities and other efforts.

Alcohol Use Disorder in the Primary Care Setting: Best Practices for Rural Communities
2022-03-23 10:30 - 12:30
Panel Discussion
Tina Christine Chasek, PhD
John Brooklyn, MD
Denise O’Connel, MSW, and Mary Lindsey Smith, PhD, MSW
March 23, 2022 from 10:30am–12:30pm ET
This presentation will focus on treating alcohol use disorder (AUD) in rural primary care settings. Our panel will address the extent of rural alcohol use, specific rural barriers to treatment, clinical management of alcohol use disorders, and best practices for treatment program design.
Learning Objectives:
1) Understand the importance of screening in novel ways for mental health and substance use in rural communities.
2) Discuss ways rural communities can spread awareness about AUD.
3) Understand the biological basis for treating alcohol users with medications in the office.
4) Learn how to reframe the message around alcohol ingestion.
5) Understand organizational and provider-level barriers to addressing unhealthy alcohol use in rural primary care settings as well as successful strategies that can be implemented to mitigate these challenges.
6) Describe the necessary steps to create and coordinate an effective and efficient, team-based practice model for alcohol screening and patient care in rural primary care practices.
Register Now

Addressing OUD in Black, Indigenous, and People of Color (BIPOC) Communities ﻿Part 1: Treatment and Recovery for African American Communities
2022-03-29 16:00 - 17:00
Presenters:
Michelle Durham, MD, MPH, Boston University School of Medicine/Boston Medical Center
Andre Johnson, MA, Detroit Recovery Project
Sponsor: American Academy of Addiction Psychiatry (AAAP) and National Council on Mental Wellbeing (NCMW)
Cost: No Fee
Target audience: Physicians, nurses, pharmacists, physician assistants, psychologists, social workers, peer recovery support specialists, and the interprofessional team
Credit designations available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit and IPCE credit
About the webinar: Between 2018 and 2019, the rate of opioid-related deaths among African Americans increased by 38%. Despite these rising rates of drug overdoses in African American communities, attention to the drug overdose crisis and opioid epidemic has focused primarily on White suburban and rural communities. This webinar will address the unique challenges and social determinants that hinder access to quality care for many African Americans. Additionally, we will review opioid use disorder treatment and harm reduction options, as well as explore the use of peer support services to engage African Americans in appropriate services.
Educational objectives: At the conclusion of this activity participants should be able to:

Identify existing disparities in access to quality substance use treatment and recovery services for African Americans
Discuss the contextual issues and treatment barriers that impact rates of opioid use disorder (OUD) and opioid overdoses in African American populations
Explore the use of specific outreach strategies and recovery supports to increase access and engagement in care for African Americans
Examine the use of effective harm reduction strategies within African American communities

Register Now

Rx Drug Abuse & Heroin Summit
2022-04-18 - 2022-04-21
For more information and to register for this event, please visit their website.
Description:
It’s Time to Turn This Epidemic Around.
More than one million too many lives have been lost to the opioid and addiction epidemic. It’s time to reverse the numbers and re-discover hope. Rx Summit is a global community of stakeholders “from federal to family” who come together annually to share best practices and strategies for prevention, treatment, and recovery. We look forward to returning to an in-person format this year, where we can continue to collaborate, cultivate change, and create solutions. This is our most important year yet.
Registration is open. Join us for the largest, most influential annual conference addressing the opioid and addiction crisis. Reserve your spot today while rates are low.

Pharmacology of Fentanyl and Its Implications for Treatment of Opioid Use Disorder
2022-04-20 12:00 - 13:00
Sandra Comer, PhD, professor of neurobiology in the Department of Psychiatry at Columbia University, will discuss the pharmacological effects of fentanyl and how they differ from other mu opioid receptor-selector agonists. She will also present current clinical data on how fentanyl is affecting treatment of opioid use disorder and describe how biologics such as vaccines and monoclonal antibodies may be used to address the fentanyl crisis.
Dr. Comer is Director of the Opioid Laboratory in the Division of Substance Use Disorders at Columbia University Irving Medical Center. Her current research focus is on the clinical testing of medications for treating opioid use disorder, methods to maximize the use of naloxone by opioid users, and evaluations of the comparative abuse liability of prescribed pain medications. Dr. Comer is a past president of the College on Problems of Drug Dependence (CPDD) and is currently the Public Policy for CPDD. She received her BS at Vanderbilt University and her PhD at the University of Michigan for her research on the effects of drugs using preclinical models. She has written more than 160 publications related to substance use disorder and provided expert testimony, reports, and presentations to congressional subcommittees, the FDA, and the World Health Organization Expert Advisory Panel on Drug Dependence.

Register Now

Mental Health and Addiction Parity: Ensuring Equal Coverage in Medicaid and Marketplace Plans
2022-04-26 14:00 - 15:00
A Webinar from The Kennedy Forum Featuring U.S. Secretary of Health and Human Services Xavier Becerra
The COVID-19 pandemic has exacerbated an existing mental health and addiction crisis in this country. One that is fueling soaring rates of depression and anxiety, driving fatal overdoses, and changing the trajectory of countless young lives. Awareness of this impact is not enough. People need better access to quality, affordable mental health and addiction care now.
Fortunately, the Biden Administration has prioritized enforcement of the Mental Health Parity and Addiction Equity Act, which requires health plans in the individual, small and group markets, and health insurance issuers to cover mental health and addiction treatment no more restrictively than physical health treatment. In its 2022 report, the Department of Health and Human Services, with the Departments of Labor and Treasury identified numerous compliance issues that continue to serve as barriers to accessing needed care. While the Department of Labor enforces parity in employer-sponsored plans, the Department of Health and Human Services (HHS) plays a critical role in helping to ensure parity in Medicaid managed care plans, Alternative Benefit Plans, Children’s Health Insurance Programs, ACA marketplace plans, and self-funded state and local government plans. These types of plans cover tens of millions of Americans, including a disproportionate number of Black, Indigenous, and People of Color (BIPOC) and children.
Join The Kennedy Forum’s latest webinar to hear directly from HHS Secretary Xavier Becerra about the department’s new parity efforts. Other esteemed panelists, including former U.S. Rep. Patrick J. Kennedy, lead author of the 2008 Mental Health Parity and Addiction Equity Act, will join in this important conversation about the future of mental health and addiction care.
Focus Areas to Include
New statutory requirements requiring many health plans to conduct detailed parity analyses
Common parity violations and how they inhibit access to care
How HHS is enforcing parity in collaboration with states
Generally accepted standards of care and the impact of new state laws requiring plans to follow for these standards
Gaps in the Parity Act, including self-funded state and local plan opt outs and the lack of parity requirements in Medicare and traditional Medicaid

Register here

Pregnancy, Parenting, And Substance Use: Stigma, Fear and a Call for Improved Messaging to our Families
2022-05-04 12:00 - 13:00
Presenter: Marjorie Meyer, MD, Professor of Obstetrics, Gynecology, and Reproductive Sciences, UVM Larner College of Medicine
Date & Time: May 4, 2022 from 12-1pm ETThis presentation will cover unique barriers that people with opioid use disorder face when pregnant and parenting.
Learning Objectives:

Learn about the stigma pregnant people with substance use face in medical facilities
Identify barriers unique to patients living in rural communities
Consider different interventions for reducing community stigma
Discuss ways to reduce self-stigma and increase help seeking behaviors

Register

Treating Hepatitis C Among People Who Use Drugs
2022-05-10 12:00 - 13:00
Register Now

https://bit.ly/APAmay

Presenter: Judith Tsui, MD, MPH, Associate Professor, University of Washington
Sponsors: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP)
Cost: No Fee
Target audience: This activity is designed for interprofessional teams, nurses, pharmacists, physician assistants, physicians, psychiatrists, and social workers. This activity is accredited for interprofessional teams, nurses, pharmacists, physician assistants, physicians, and social workers.
Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit, IPCE credit
About the webinar: The Hepatitis C Virus is an RNA virus that is not vaccine preventable and is the most common blood-borne infection in the U.S. The majority of people exposed to the virus will develop chronic infection, and it has evolved into an intergenerational epidemic; baby boomers and young people who inject drugs are the most afflicted. This webinar aims to show providers the treatment techniques when working with a patient with co-morbid SUD and HCV.
Educational objectives: At the conclusion of this activity participants should be able to:

Explain hepatitis C elimination campaigns and that prior authorization requirements and provider restrictions have been lifted.
Compare and contrast treatment techniques which are specific to people who use drugs (PWUD).
Use adult HCV screening methods and evaluate treatment methods if a patient has the infection.
Work with healthcare team to identify methods to use direct-acting antivirals (DAAs) and to implement key steps in treatment.

Suicide Prevention Across the Lifespan
2022-05-11 13:00 - 14:00
For National Prevention Week, join us for a panel discussion on suicide prevention throughout the lifespan. In this discussion, panelists will share research on interventions and emerging trends in suicide prevention from adolescence through older adulthood. Discussion will also address trends across racial and ethnic groups, considerations for working with LGBTQ+ populations, and the role of peer support in suicide.
ABOUT THE SPEAKERS
Shirley Yen, Ph.D., is an Associate Professor in the Department of Psychiatry at Harvard Medical School at Beth Israel Deaconess Medical Center, and the Training Director of the clinical psychology internship program at the Massachusetts Mental Health Center. Dr. Yen’s research focuses on identifying risk factors and developing interventions for suicidal behaviors in adolescents and adults. Dr. Yen has been an NIMH-funded investigator for the past 20+ years, and has authored over 130 peer-reviewed publications. As an investigator on prospective, longitudinal studies of youth with bipolar disorder, adults with personality disorders, and suicidal adolescents, Dr. Yen has examined prospective predictors of suicidal behavior. Dr. Yen’s research has also focused on translational work towards developing interventions to reduce suicidal behaviors. She was recently awarded an R01 from the National Institute of Mental Health, to test the effectiveness of a new intervention she developed, Skills to Enhance Positivity (STEP), in reducing suicidal behaviors in acutely suicidal adolescents. She is currently completing a short-term mixed-method prospective study using daily diary ratings that examines mechanisms of risk for suicidal and self-injurious ideation in sexual and gender minority youth, and a pilot adaptation of a yoga-based intervention for adolescents with depression.
Timothy Schmutte, Psy.D., is a clinical psychologist and mental health services researcher with a longstanding interest in older adults and suicide prevention. As an Assistant Professor at the Yale Program for Recovery and Community Health in the Department of Psychiatry at Yale University, his current research focuses on improving the quality of care provided to patients with high risk for suicide. For his research, Dr. Schmutte uses national data to examine the service use patterns and outcomes of older adults treated for suicidal thoughts and acts in acute care settings as well as to identify risk and protective factors for suicide shortly following a diagnosis of dementia. He is also currently helping to develop a peer-based intervention to help Veterans with high suicide risk as well as a clinical decision support tool for emergency department physicians in treating patients with high suicide risk.
Cheryl Gagne, Sc.D., is a Senior Associate at C4 Innovations and directs a training program for Massachusetts addiction professionals. She also served as subject matter expert, trainer, and technical assistance provider for SAMHSA’s Bringing Recovery Supports to Scale Technical Assistance Center Strategy. In this role, Cheryl developed skill-based curricula for providers including peer workers and led the team that described core competencies for peer workers for SAMHSA. Throughout her career, she has developed training interventions to meet the learning needs of diverse groups of healthcare providers and behavioral health and public health programs in the US and abroad. Her professional skills are influenced by her experiences as person in long-term recovery from bipolar and substance use disorders and the experiences of family members. Cheryl received her Doctorate of Science from Boston University.
About the webinar: This webinar is hosted by the New England Prevention Technology Transfer Center (HHS Region 1), a program funded through SAMHSA, in collaboration with the New England Mental Health technology Transfer Center, to address the suicide prevention as part of the National Prevention Week promoted through SAMHSA.
Certificates of attendance for 1 contact hour will be provided to webinar participants. No partial credit will be awarded. This webinar will be recorded.
To Register

Department of Psychiatry Virtual Grand Rounds "Implementing Technology Supported Depression and Unhealthy Alcohol Use Care in Primary Care in Colombia: The DIADA Project"
2022-05-17 08:00 - 09:00
CLICK HERE TO JOIN THE DEPARTMENT OF PSYCHIATRY VIRTUAL GRAND ROUNDS
Presenters:
Carlos Gómez-Restrepo, MD, PhD; Magda Cristina Cepeda Gil, MD; Lisa Marsch, PhD; William Torrey, MD
By the end of this lecture, participants will be able to understand:
• A novel model for scaling-up mental healthcare delivery in primary care in Colombia
• Patient level outcomes during the implementation of a novel model for scaling-up mental healthcare delivery in primary care
• Implementation level outcomes from a novel model for scaling-up mental healthcare delivery in primary care
• The impact of the COVID-19 pandemic on a population with diagnosed depression and/or unhealthy alcohol use in Colombia
• A strategy to foster international research collaboration and expand research capacity in mental health
Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Dartmouth-Hitchcock designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Crossing Fields to Make Scientific Connections: Reinforcement Processes in Addiction, Binge Eating, and Obesity
2022-05-18 12:00 - 13:00
This month, VCBH wraps up its FY22 lecture series with guest Tera Fazzino, PhD, assistant professor of psychology and associate director of the Cofrin Logan Center for Addiction Research at the University of Kansas. Dr. Fazzino will present “Crossing Fields to Make Scientific Connections: Reinforcement Processes in Addiction, Binge Eating, and Obesity” on Wednesday, May 18, 2022 at 12 PM ET.
In this presentation, Dr. Fazzino will present her work spanning the fields of addiction and obesity, which has focused on identifying and intervening upon reinforcement processes that drive health risk behaviors. She will also discuss her research in providing the first operational definition of hyper-palatable foods and examining hyper-palatable foods as a substance.
Dr. Fazzino’s research focuses on the intersection of addiction, obesity, and eating disorders. She is interested in common reinforcement processes that may contribute to behaviors associated with addiction, obesity, and eating disorders, and in the ways that highly palatable foods may influence reinforcement processes and behavior. She also utilizes new mobile technology-based methods to measure health risk behaviors in real-time in participants’ own environments. Dr. Fazzino received her PhD from the University of Vermont in experimental psychology in 2014.

Guest Presenter:
Tera Fazzino, PhD
Assistant Professor, Psychology
Associate Director,
Cofrin Logan Center for Addiction Research
The University of Kansas

“Crossing Fields to Make Scientific Connections: Reinforcement Processes in Addiction, Binge Eating, and Obesity”
When: May 18, 2022
Duration: 12 PM – 1 PM ET
Where: Zoom
Cost: Free
CMEs/CEs Available: 1.0 credit
(if attending live)

Register Now

Addressing OUD in BIPOC Communities Part 2: Treatment and Recovery for Hispanic/Latino Populations
2022-05-24 14:00 - 15:00
Presenter: Pierluigi Mancini, PhD
Sponsors: National Council for Mental Wellbeing–NCMW
Continuing education information: NOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education credit for this event. Participants will receive a Certificate of Completion.
Target Audience: Interprofessional teams, family/patients, nurses, physicians, psychiatrists, psychologists, social workers, students/educators
About the webinar: The current opioid crisis is one of the most widespread drug epidemics in U.S. history for all racial and ethnic groups, especially in Hispanic/Latino populations. In 2020, rates of drug overdose among Hispanic or Latino individuals grew by 40%, the largest annual increase since 1999. Additionally, in 2021, adolescent opioid overdose deaths increased by over 100%, with Latino adolescents experiencing the second highest increase across all races and ethnicities. Further, research has found that Latino individuals with opioid use disorder often experience healthcare disparities, which are exacerbated by social and cultural factors, including the stigma linked to mental illness and treatment in Hispanic culture. This webinar will address the unique sociocultural factors that influence opioid use and access to prevention, treatment and recovery among Hispanic/Latino populations, and will discuss strategies to enhance engagement in care.
Educational objectives:

Explore the current state of drug overdose and opioid use disorder among Hispanic/Latino populations.
Identify health disparities in access to quality substance use treatment and recovery services for Hispanics/Latinos.
Discuss the contextual issues and treatment barriers that impact rates of opioid use disorder (OUD) and opioid overdose in Hispanic/Latino populations.
Explore public health approaches and recovery supports to increase access and engagement in treatment for Hispanics/Latinos.

Register Now
